Walmart blasts CVS drug middleman role, ends business relationship
Published by The Columbus Dispatch
Walmart declared war on CVS when it blasted the pharmacy giant Tuesday and announced it will stop doing most business with CVS’s pharmacy benefit manager.
Walmart said that effective April 30, it will end all interaction with CVS Caremark except its Medicare Part D plans. Walmart’s Sam’s Club stores also remain in the CVS Caremark network, CVS said in a statement.
In its statement, Walmart said CVS Caremark is sapping value from Walmart customers and steering customers to pharmacies of CVS’s choosing — presumably CVS’s own.
“We are committed to offering our customers accessible and affordable health care, and an important way we do that is to make sure our partners are working with us in good faith to establish fair and equitable terms, so we can pass savings to our customers through everyday low prices,” the Walmart statement said.
“We are committed to providing value to our customers across our business, including our pharmacy, but we don’t want to give that value to the middle man. This issue underscores the problems that can arise when a PBM can exert their unregulated power to direct members on where to fill their scripts, disrupting patients’ health care. Walmart is standing up to CVS’s behaviors that are putting pressure on pharmacies and disrupting patient care.”
CVS spokesman Michael DeAngelis said Walmart was demanding that CVS Caremark pay too much for the prescriptions Walmart filled.
“At a time when everyone is working hard to find ways to reduce health care costs, Walmart’s requested rates would ultimately result in higher costs for our clients and consumers,” DeAngelis said in an email. “The decision to leave the CVS Caremark commercial and managed Medicaid retail pharmacy networks was Walmart’s, and Walmart’s alone. We’ve requested that Walmart ease the transition for affected members by continuing to fill prescriptions as an in-network participating pharmacy through April 30.”
The news comes at a difficult time for CVS, which is trying to convince a federal judge that a merger with insurance giant Aetna won’t put the company in a position to engage in anti-competitive practices.
As a pharmacy benefit manager, CVS Caremark represents health plans, negotiating rebates with drug manufacturers and reimbursing retail pharmacies for the drugs they dispense. But many have questioned how CVS could fairly control reimbursements to retail pharmacies with whom CVS is in direct competition as the nation’s No. 1 pharmacy retailer.
For the past year, The Dispatch has documented Ohio independent pharmacists’ complaints that CVS cut reimbursements below their costs and then sent letters offering to buy their pharmacies. The paper also has reported that CVS Caremark and other PBMs have disrupted care for cancer patients by forcing them out of their clinics’ pharmacies to get their expensive cancer drugs from the PBMs’ own mail-order outlets. In addition, The Dispatch has reported how the Ohio Department of Health requires people who receive federal assistance to get their HIV drugs from CVS even though CVS in 2017 potentially exposed the HIV-positive status of thousands in a mailing.
“We have said from the start that Ohio’s PBM problem goes well beyond reimbursement struggles for independent pharmacies — this issue is impacting all pharmacies, large and small,” said Antonio Ciaccia of the Ohio Pharmacists Association. “With hundreds of pharmacy closures, and most recently, CVS’s cannibalization of Ritzman Pharmacies, it is easy to see that CVS is driving Ohio’s pharmacy marketplace off a cliff … I think it’s safe to say that Walmart has seen enough and is unwilling to be a part of CVS’s pricing arbitrage that is costing Ohioans millions.”
CVS recently bought 20 Ritzman drugstores in northeast Ohio. It is closing 17 and reopening at least two of the remaining three as CVS stores.
In a corporate statement, CVS downplayed the loss of most of Walmart’s business, saying “less than 5 percent of affected CVS Caremark members use Walmart exclusively to fill their prescriptions.” However, that 5 percent represents 4.65 million people, given that CVS said Caremark covers 93 million people.
DeAngelis said that people represented by CVS Caremark who now get their medicine at Walmart shouldn’t have trouble finding a new pharmacy.
“We expect that prescriptions previously filled at Walmart will move to a number of different pharmacies in our network, including nearby independently-owned, community-based pharmacies, other local pharmacies in grocery stores and mass merchants, as well as regional and national chains,” he said. “Even without Walmart, there are more than 63,000 pharmacies that will remain in our national network. And in Ohio, more than 2,200 pharmacies remain in our network, including more than 720 independent pharmacies. The bottom line is that members will continue to have choice based on their plan design.”
Click here to see the original article on the Columbus Dispatch website.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.